The American Heart Association will honor Annet Kirabo, D.V.M., Ph.D., FAHA, with the 2026 Joseph A. Vita Award at its Scientific Sessions 2026, recognizing her pioneering discoveries on how immune activation and inflammation contribute to high blood pressure. Dr. Kirabo, a professor of medicine at Vanderbilt Health, will receive the award during the Opening Session on Saturday, Nov. 7, at the meeting held Nov. 6-9 in Chicago. The award, named after the late cardiovascular scientist Joseph A. Vita, M.D., is presented annually to a scientist whose research has significantly advanced cardiovascular biology or health within the past five years, as published in the Association's journals.
Dr. Kirabo's work has fundamentally changed the understanding of hypertension by demonstrating that lipid oxidation-derived protein adducts act as neoantigens that trigger antigen-presenting cell activation, T-cell responses, vascular dysfunction and hypertension. This discovery revealed a paradigm shift in cardiovascular biology, showing how the immune system drives blood pressure regulation. Her laboratory now combines immunology, vascular biology, genomics, metabolomics and single-cell technologies to identify new therapeutic strategies for cardiovascular and kidney disease, with potential targets including reactive lipid molecules called isolevuglandins and sodium-sensing pathways in immune cells.
Manesh R. Patel, M.D., FAHA, the American Heart Association's 2026-2027 volunteer president, praised Dr. Kirabo's impact: "Her pioneering discoveries represent a paradigm shift in cardiovascular biology, reshaping our understanding of hypertension by revealing how immune activation and inflammation drive cardiovascular disease." The award is selected by the editors-in-chief of the Association's 14 peer-reviewed journals and celebrates research that transforms or changes the direction of cardiovascular science. Dr. Kirabo has published more than 230 scientific papers, including influential articles in the Hypertension journal, where she has served on the editorial board since 2018, and as an associate editor of Circulation Research since 2019.
Beyond her research, Dr. Kirabo has been an active American Heart Association volunteer since 2009, serving on the Council on Hypertension Communications Committee, including as chair from 2022 to 2024, and on the Council Operations Committee since 2024. She has reviewed research proposals and chaired sessions at scientific meetings. "I am deeply honored to receive the Joseph A. Vita Award from the American Heart Association, an organization that has supported my career from my predoctoral and postdoctoral fellowships through my development as an independent investigator," Dr. Kirabo said. She earned her veterinary medicine degree from Makerere University in Uganda, a master's in cell and molecular biology from St. Cloud State University, and a doctorate in physiology and functional genomics from the University of Florida, followed by postdoctoral training at Vanderbilt University.
The recognition underscores the growing importance of immunology in cardiovascular medicine, potentially leading to novel treatments for hypertension that affects millions worldwide. Dr. Kirabo's mentorship of dozens of trainees who have advanced to faculty positions also shapes the future of cardiovascular research. The award highlights how understanding immune mechanisms can open new avenues for preventing and treating heart and kidney diseases. For more information about the American Heart Association's work, visit heart.org or stroke.org. Additional resources, including multimedia, are available on the release link, and the original announcement can be viewed at www.newmediawire.com.
